| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2082943 | Drug Discovery Today: Therapeutic Strategies | 2008 | 7 Pages |
Abstract
Restoration of cardiovascular function is the ultimate goal of stem-cell-based therapy. In principle, cardiovascular stem cells can improve cardiac function via de novo cardiomyogenesis, enhanced myocardial neovascularization and prevention of postinfarct remodeling. Stem cell transplantation to improve cardiac function has received mixed results in human clinical trials. These early data suggest that a crucial reassessment of the scientific basis to stem-cell-based therapy is needed to bring this highly promising treatment modality to mainstream clinical care.
Section editor:Jay Edelberg – Bristol-Myers Squibb Co, Pennington, NJ 08534, USA
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Yuan-Hung Liu, Ravi Karra, Sean M. Wu,